Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 56
- Press Release
- Press Release PharmAbcine’s Phase 1 Ophthalmology Program PMC-403 Selected by the KDDF for Government-initiated Drug Development Program
- PharmAbcine
- 6 Dec 2023
- Views2653
- 0
- 55
- Press Release
- Press Release PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
- PharmAbcine
- 23 Nov 2023
- Views2326
- 0
- 54
- Press Release
- Press Release PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data
- PharmAbcine
- 9 Nov 2023
- Views2412
- 0
- 53
- Press Release
- Press Release PharmAbcine Receives HREC Approval in Australia for the Phase 1a/b Trial of Its Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)
- PharmAbcine
- 18 Sep 2023
- Views2455
- 0
- 52
- Press Release
- Press Release PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
- PharmAbcine
- 24 May 2023
- Views3306
- 0
- 51
- Press Release
- Press Release PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)
- PharmAbcine
- 13 Dec 2022
- Views3248
- 0
- 50
- Press Release
- Press Release PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week
- PharmAbcine
- 9 Dec 2022
- Views2144
- 0
- 49
- Press Release
- Press Release PharmAbcine to participate in Jefferies 2022 London Healthcare Conference
- PharmAbcine
- 25 Oct 2022
- Views1682
- 0
- 48
- Press Release
- Press Release PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022
- PharmAbcine
- 18 Oct 2022
- Views1906
- 0
- 47
- Press Release
- Press Release PharmAbcine to Participate in BIO-Europe 2022
- PharmAbcine
- 27 Sep 2022
- Views1523
- 0